(Q35005258)

5 August 2017

1 reference

title

Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis - a critical review (English)

1 reference

5 August 2017

0 references

Chlamydia pneumoniae

1 reference

Human herpesvirus 6

1 reference

Robert H Swanborg

1

1 reference

5 August 2017

Judith A Whittum-Hudson

series ordinal

2

1 reference

5 August 2017

Alan P Hudson

series ordinal

3

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

published in

Microbes and Infection

1 reference

5 August 2017

volume

4

1 reference

5 August 2017

issue

13

1 reference

5 August 2017

page(s)

1327-1333

1 reference

Validity of the epidemics of multiple sclerosis in the Faroe Islands

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Chlamydia pneumoniae and multiple sclerosis: no significant association

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Not so fast: research on infectious links to MS questioned

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Human herpesvirus 6: An emerging pathogen.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Virus receptor arrays, CD46 and human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

A potential role for human herpesvirus type 6 in nervous system disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

A virus-induced molecular mimicry model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Background and current knowledge of Chlamydia pneumoniae and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Chlamydia pneumoniae associated with central nervous system infections

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

APOE genotype is a major predictor of long-term progression of disability in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

Understanding multiple sclerosis: lessons from pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900009-6

7 January 2021

10.1016/S1286-4579(02)00009-6

Identifiers

DOI

1 reference

5 August 2017

1 reference